Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Quince Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 88
- −14 vs. Q4 2021
- Shares held
- 16.9M
- −2.31M (−12.0%) vs. Q4 2021
- Total value
- $99.5M
- −$143.3M (−59.0%) vs. Q4 2021
- New holders
- 10
- 22 more added
- Sold out
- 24
- 35 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jefferies Group LLC | 0 | $0 | 0.00% | −20,250−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,753−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −7,212−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −5,792−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,803−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −491−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −431−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −7−100.0% | Sold out |